Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, April 30, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Moleculent Raises $20 Million to Expand Functional Profiling Platform
Life Sciences Times
-
April 30, 2026
Venture Capital
AcuityMD raises $80 million to expand AI platform for medical device industry
Life Sciences Times
-
April 21, 2026
Venture Capital
Orthogon Therapeutics Secures $11 Million to Advance BK Virus Antiviral Program
Life Sciences Times
-
April 17, 2026
Venture Capital
Alloy Therapeutics Raises $40 Million, Reaches $1 Billion Valuation to Expand AI-Driven Drug Development Platform
Life Sciences Times
-
April 15, 2026
Venture Capital
Jeito Capital Leads $75 Million Funding Round to Advance Adcendo Cancer Drug Pipeline
Life Sciences Times
-
April 14, 2026
Venture Capital
Prudentia Sciences Raises $20 Million Series A to Advance AI-Driven Due Diligence in Life Sciences Dealmaking
Life Sciences Times
-
January 7, 2026
0
Pharma
Helus Pharma Rebrands and Begins Trading on Nasdaq as It Advances Mental Health Drug Portfolio
Life Sciences Times
-
January 5, 2026
0
Venture Capital
Johnson & Johnson Completes Acquisition of Halda Therapeutics
Life Sciences Times
-
December 29, 2025
0
Venture Capital
Startup Shutdowns Shift to Later Stages as First AI Reckoning Emerges, Report Finds
Life Sciences Times
-
December 23, 2025
0
Venture Capital
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx in $55.5 Million Deal
Life Sciences Times
-
December 23, 2025
0
Venture Capital
Vyome Subsidiary LiveChain Moves to Acquire Senior Secured Note in MIT-Backed Humanyze
Life Sciences Times
-
December 22, 2025
0
Venture Capital
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Neurable Raises $35 Million Series A to Expand Everyday Brain-Computer Interface Technology
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Cosette Pharmaceuticals Terminates Agreement to Acquire Mayne Pharma
Life Sciences Times
-
December 12, 2025
0
Venture Capital
Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option
Life Sciences Times
-
December 12, 2025
0
1
2
3
4
...
112
Page 3 of 112
Most Read
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
April 30, 2026
Johnson & Johnson Names Ryan Koors Vice President of Investor Relations
April 30, 2026
Moleculent Raises $20 Million to Expand Functional Profiling Platform
April 30, 2026
Komodo Health Names Paul Thomas Chief Financial Officer
April 30, 2026